146
Participants
Start Date
February 11, 2022
Primary Completion Date
December 4, 2024
Study Completion Date
February 14, 2025
Bifidobacterium longum
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome
University of Calgary, Calgary
University Of Alberta, Edmonton
Eastern Regional Health Authority, St. John's
Medicor Research Inc., Greater Sudbury
McMaster University, Hamilton
Scott Shulman Medicine Professional Corporation, North Bay
The Ottawa Hospital General Campus, Ottawa
Canadian Phase Onward Inc., Toronto
Diex Recherche Quebec Inc., Québec
DIEX Recherche, Saint-Charles-Borromée
PerCuro Clinical Research Ltd., Victoria
Collaborators (3)
Syneos Health
OTHER
Medidata Solutions
INDUSTRY
McMaster University
OTHER
CaligorRx, Inc.
UNKNOWN
Société des Produits Nestlé (SPN)
INDUSTRY